T3D THERAPEUTICS INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are MARSHALL BARRY JAMES, CELATOR PHARMACEUTICALS INC and AI THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Didsbury John Robert | 7 |
#2 | Didsbury John R | 3 |
#3 | Didsbury John | 2 |
#4 | John Robert Didsbury | 1 |
Publication | Filing date | Title |
---|---|---|
US2018153860A1 | Methods of dose administration for treating or preventing cognitive impairment using indane acetic acid derivatives | |
US2018153859A1 | Methods of treating or preventing cognitive impairment using indane acetic acid derivatives based on apoe4 genotype | |
AU2016235263A1 | Methods of treating liver disease using indane acetic acid derivatives |